iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. Segments The company reports in two segments, Cancer Detection (Detection) and Cancer Therapy (Therapy). Cancer Detection segment In this segment the company's solution includes Advanced Image Analysis and Workflow Solutions. The company develops and markets a range of CAD solutions for digital mammography systems. Its SecondLook Digital CAD is based on patented algorithms that analyze the data, automatically identifying and marking suspicious regions in the images. The CAD provides the radiologist with a ‘second look’, which helps the radiologist detect actionable missed cancers earlier than screening mammography alone. SecondLook detects and identifies suspicious masses and micro-calcifications utilizing image processing, pattern recognition and artificial intelligence techniques. The company offers mammography CAD products, PowerLook Advanced Mammography Platform (AMP). The technology expands on its SecondLook platform and is the CAD platform upon which all future breast imaging CAD offerings from iCAD would be built. PowerLook AMP incorporates both the SecondLook Digital and the SecondLook Premier CAD algorithms. PowerLook AMP’s CAD metrics offer tissue and lesion characteristics to support the breast imager’s workflow. In addition, PowerLook AMP is the first product of its kind to integrate a breast density software package which aids radiologists by standardizing their approach to breast density assessment. The company acquired the breast density solution from VuComp in April 2015 and subsequently released it to market under the product name iReveal. Included with PowerLook AMP is a multi-vendor CAD server that allows hospitals and imaging facilities to connect up to four mammography acquisition devices. This reduces the need for separate CAD servers while lowering hardware and service costs. The company’s PowerLook AMP also provides a DICOM connectivity solution enabling universal compatibility with picture archiving and communication systems (PACS) and Review Workstations. PowerLook Advanced Mammography Platform PowerLook AMP is designed to function with digital mammography systems (FFDM and computed radiography), including systems sold by GE Healthcare, Siemens Medical Systems, Fuji Medical Systems, Hologic, Inc., Sectra Medical Systems, Philips, IMS Giotto, Agfa Corporation, and Planmed. PowerLook AMP is a computer server residing on a customer’s network that receives patient studies from the imaging modality, performs CAD analysis and sends the CAD results to PACS and/or review workstations. Magnetic Resonance Imaging (MRI) The company has a strategic partnership agreement with Invivo Corp., a subsidiary of Philips Healthcare. With this agreement, it began developing the DynaCAD product software for breast and prostate MR image analysis workstations to help radiologists find cancer earlier. DynaCAD offers a suite of FDA-cleared dynamic contrast enhanced (DCE) MRI analysis solutions for breast, prostate, and other organs. Each of the three modules delivers objective, consistent quantitative analysis of DCE MR images. The DynaCAD software automates the process of drawing regions of interest, minimizing potential errors inherent in manual processes. Once a region of interest has been identified, an algorithm analyzes changes in the MR signal in the tissue to help clinicians discern biological processes taking place in malignant versus benign tumors. VeraLook The company offers VeraLook, a CAD solution that is designed to support detection of colonic polyps in conjunction with CTC. The system works in conjunction with third party display workstations and PACS vendors. Cancer Therapy segment This segment offers Xoft eBx system that utilizes a miniaturized high dose rate yet low energy X-ray source to apply radiation directly to the cancerous site. The Xoft eBx system delivers clinical dose rates similar to traditional radioactive systems. Customers of the Xoft eBx system include university research and community hospitals, private and g
(ICAD:Consolidated Issue listed on NASDAQ Capital Market)
98 Spit Brook Road
Nashua, NH 03062
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for ICAD.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact ICAD INC, please visit www.icadmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.